No Data
Sector Update: Health Care Stocks Lower in Afternoon Trading
Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?
Kazia Therapeutics Shares Drop After FDA Derails Fast Track of Potential Brain Cancer Drug
Kazia Says It Evaluates Next Steps In NDU Glioblastoma; Believes Paxalisib Shows Potential To Be Evaluated In Breast Cancers
Express News | Kazia Therapeutics Ltd - Aligns With FDA on Phase 3 Study Design
Express News | Kazia Therapeutics Ltd - FDA Says Os Data Not Appropriate for Accelerated Approval
blessings u : It's not suitable for acceleration, have to wait a few years.